ELISA CIP2A anti-

Quantity:100µg Purification:protein A+G purified Form:liquid Purity:?95% as determined by SDS-PAGE Host:Mouse Clonality:monoclonal Clone ID:9H8 Isotype:IgG1 Storage:PBS with 0.1% proclin300, pH 7.4,-20? for 12 months(Avoid repeated freeze / thaw cycles.) Background:Cancerous inhibitor of protein phosphatase 2A (CIP2A) was originally identified as a cellµLar protein phosphatase 2A (PP2A) inhibitor, and has been shown to control oncogenic cellµLar signals by suppressing the tumor suppressor PP2A. CIP2A overexpression has been found in several malignancies including breast cancer, hepatocellµLar carcinoma, gastric cancer, head and neck cancer, colon cancer, prostate cancer and non-small cell lung cancer. CIP2A is a 83~102 kDa cytoplasmic protein. Immunogen:KIAA1524 Synonyms:Cancerous inhibitor of PP2A, CIP2A, KIAA1524, p90, p90 autoantigen, Protein CIP2A Observed MW:102 kDa Uniprot ID:Q8TCG1 Reactivity:, Rat Tested Application:ELISA, WB Recommended dilution:WB: 1:1000 - 1:10000 Gene ID:57650 Research Area: